Aarti Industries PAT has jumped by 31.9 per cent at Rs 69.6 crore in Q4FY16
Chirag Gothi / 06 May 2016
Aarti Industries, a diversified chemicals player, has posted a standalone net profit that has jumped by 31.9 per cent at Rs 69.6 crore for the quarter ended December 31, 2016 as against Rs 52.76 crore in the corresponding quarter of the previous year.
Aarti Industries, a diversified chemicals player, has posted a standalone net profit that has jumped by 31.9 per cent at Rs 69.6 crore for the quarter ended December 31, 2016 as against Rs 52.76 crore in the corresponding quarter of the previous year.
The company’s standalone revenue marginally has grown by 3.1 per cent at Rs 698.7 crore in Q4FY16. Its standalone operating profit (EBITDA) has grown by 15.4 per cent at Rs 136.8 crore along with operating profit margin expanding by 208 bps for the current quarter, i.e. at 19.58 per cent.
Pharmaceuticals segment has reported growth of 46.6 per cent at Rs 119.8 crore which contributes to around 17 per cent of the total revenue of the company. EBIT level of this segment has been reported around 11.69 per cent margin. Speciality chemical segment, which is a bigger part of the company contributes to around 77-78 per cent of the company's total revenue, however it’s reported a flat growth; while EBIT level profit grew by 14.8 per cent 65 along with EBIT margin expanded by 326 bps to 22.25 per cent in Q4FY16.
For the entire period of FY16, it has reported standalone net profit growth of 34.4 per cent at Rs 252.4 crore, while its revenue marginally de-grew by 5.35 per cent at Rs 2,717 crore. Its standalone operating profit (EBITDA) has grown by 16.4 per cent at Rs 520 crore along with operating profit margin expanding by 308 bps for the current quarter at 19.5 per cent.
The group has a strong market position in the benzene-based specialty chemicals segment. It also has a full-fledged research and development centre, recognised by the Department of Scientific and Industrial Research, Government of India. It is expanding existing capacities where it already has global leaderships, venturing into new chemistries with firm off-take commitments, and targeting higher utilisation of pharmaceutical facilities.
On valuation front, it is currently trading at 17.5 times, price to earnings ratio per share of Rs 30.30 as on March 31, 2016. Today stock price has closed at Rs 5.40 or 1.03 per cent higher at Rs 531.40 per share.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.